Trials / Completed
CompletedNCT06207435
Community Support Program for Lung Cancer Screening
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 242 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Accepted
Summary
The research study aims to create a program for lung cancer screening attendance
Detailed description
The overall objective of this project is to demonstrate the impact of a community support program (CSP) on improving adherence to LCS follow-up guidelines in an urban environment. The project aims to collaborate with community partners to develop an infrastructure and iterative process to provide social support to community members that facilitates obtaining their follow-up LDCT for LCS. It utilizes novel population level data that includes geospatial analysis of neighborhood-level data of patients residing in Philadelphia who have received a LDCT for LCS. This allows for targeted community level interventions and the ability to evaluate impact on a population level. A Community Support Program Representative will reach out to eligible patients via telephone. The CSP Representative and Patient Navigator will communicate with consented patient directly, assist with travel and the appointment. The PN will log the date of the appointment, zip code of the patient and the adherence (or lack of) of the appointment completion. We will utilize Lyft transportation vouchers to provide rides to participants from their home location in West Philadelphia to and from the Penn Medicine downtown hospital locations on the day of their LDCT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Transportation | Eligible patients are contacted and offered free transportation to and from their upcoming appointment. |
Timeline
- Start date
- 2023-02-10
- Primary completion
- 2024-08-12
- Completion
- 2024-08-30
- First posted
- 2024-01-17
- Last updated
- 2025-09-02
- Results posted
- 2025-09-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06207435. Inclusion in this directory is not an endorsement.